In mild stages, lesions are generally small and superficial, often containing minimal lesions in the pelvic region, with limited spread
The first sustained visible change is usually around session four, at the 6-to-8-week mark, when surface texture begins to refine and the morning-mirror impression of the face stops being identical to the pre-treatment baseline
So that's also in there
Makaronidis has received institutional funding from Novo Nordisk and Rhythm Pharmaceuticals, and research funding from the NIHR, the Sir Jules Thorne Charitable Trust and the Society for Endocrinology (UK)
However, in a sensitivity analysis of the REWIND study with dulaglutide, the relative risk reduction for a 40% or 50% decrease in eGFR was 30% and 44%, both significant, in the dulaglutide group compared to placebo, respectively.92 This lower risk of developing macroalbuminuria was also confirmed in an exploratory analysis of the ELIXA (lixisenatide) study.93 In the EXSCEL study (exenatide LAR), renal episodes were analyzed as additional microvascular episodes, and no differences were observed in the risk of episodes related to decreased eGFR, but differences were observed in the composite episode, which included decreased eGFR and macroalbuminuria, although only after adjustment94 (Table 2)